Do you want to read an article? Please log in or register.
Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer
Lung, Respiratory and Thoracic Cancer
RECOMMENDED
Related content
Lung, Respiratory and Thoracic Cancer
Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Duvergé L, Bondiau PY, Claude L, Supiot S, Vaugier L, Thillays F, Doyen J, Ricordel C, Léna H, Bellec J, Chajon E, de Crevoisier R, Castelli J
doi: 10.1016/j.lungcan.2021.05.016
Lung, Respiratory and Thoracic Cancer
Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer
Lung Cancer
Baine MJ, Verma V, Schonewolf CA, Lin C, Simone II CB
doi: 10.1016/
Lung, Respiratory and Thoracic CancerRadio-Oncology
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients with Early-Stage Non-Small Cell Lung Cancer
J Thorac Oncol.
Moreno AC, Fellman B, Hobbs BP, Liao Z, Gomez DR, Chen A, Hahn SM, Chang JY, Lin SH
doi: 10.1016/j.jtho.2019.08.2505.
Lung, Respiratory and Thoracic CancerRadio-Oncology
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
Lancet Oncol
Altorki NK, McGraw TE, Borczuk AC, Saxena A, Port JL, Stiles BM, Lee BE, Sanfilippo NJ, Scheff RJ, Pua BB, Gruden JF, Christos PJ, Spinelli C, Gakuria J, Uppal M, Binder B, Elemento O, Ballman KV, Formenti SC
doi: 10.1016/S1470-2045(21)00149-2
Lung, Respiratory and Thoracic CancerRadio-Oncology
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer
Radiother Oncol.
Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Hoyer M, Hurkmans C, Lang S, Lartigau E, Méndez Romero A, Senan S, Verellen D
doi: 10.1016/j.radonc.2017.05.012.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial
JAMA Oncol.
Palma DA, Nguyen TK, Louie AV, Malthaner R, Fortin D, Rodrigues GB, Yaremko B, Laba J, Kwan K, Gaede S, Lee T, Ward A, Warner A, Inculet R
doi: 10.1001/jamaoncol.2018.6993.
Lung, Respiratory and Thoracic Cancer
Association of Survival With Adjuvant Chemotherapy Among Patients With Early-Stage Non-Small Cell Lung Cancer With vs Without High-Risk Clinicopathologic Features
JAMA Oncol.
Pathak R, Goldberg SB, Canavan M, Herrin J, Hoag JR, Salazar MC, Papageorge M, Ermer T, Boffa DJ
doi: 10.1001/jamaoncol.2020.4232.
Lung, Respiratory and Thoracic CancerRadio-Oncology
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
Lancet Oncol
Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA, STARS Lung Cancer Trials Group.
doi: 10.1016/S1470-2045(21)00401-0
Lung, Respiratory and Thoracic Cancer
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve
Eur J Cancer.
Guberina N, Pöttgen C, Schuler M, Guberina M, Stamatis G, Plönes T, Krebs B, Metzenmacher M, Theegarten D, Gauler T, Jöckel KH, Darwiche K, Aigner C, Stuschke M, Eberhardt WE
doi: 10.1016/j.ejca.2020.07.025.